Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 23850450

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2013 Oct
First author
Vriens BE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Vriens BE
      type
      Author
    2. name
      Aarts MJ
      type
      Author
    3. name
      de Vries B
      type
      Author
    4. name
      van Gastel SM
      type
      Author
    5. name
      Wals J
      type
      Author
    6. name
      Smilde TJ
      type
      Author
    7. name
      van Warmerdam LJ
      type
      Author
    8. name
      de Boer M
      type
      Author
    9. name
      van Spronsen DJ
      type
      Author
    10. name
      Borm GF
      type
      Author
    11. name
      Tjan-Heijnen VC
      type
      Author
    12. name
      Breast Cancer Trialists' Group of the Netherlands (BOOG)
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Vriens BE
      type
      Author
    2. name
      Aarts MJ
      type
      Author
    3. name
      de Vries B
      type
      Author
    4. name
      van Gastel SM
      type
      Author
    5. name
      Wals J
      type
      Author
    6. name
      Smilde TJ
      type
      Author
    7. name
      van Warmerdam LJ
      type
      Author
    8. name
      de Boer M
      type
      Author
    9. name
      van Spronsen DJ
      type
      Author
    10. name
      Borm GF
      type
      Author
    11. name
      Tjan-Heijnen VC
      type
      Author
    12. name
      Breast Cancer Trialists' Group of the Netherlands (BOOG)
      type
      CollectiveName
    bibliography ids
    1. nci-bib-e05644f1f4e491ae2835a48a
    book metadata
    content sha256
    d9b6cf204647909e65f328355cf7e8c67a33f1051bc9258ae739e93b479a4242
    document type
    citation
    dois
    1. 10.1016/j.ejca.2013.06.012
    electronic publication date
    display
    2013 Jul 10
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23850450
    immutable id
    pubmed:23850450@d9b6cf204647909e65f328355cf7e8c67a33f1051bc9258ae739e93b479a4242
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    1879-0852
    issn print
    0959-8049
    issue
    15
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    3102-10
    volume
    49
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23850450
      provenance
      batch id
      0a08f044391426feb8ef
      provider
      NCBI PubMed ESummary
      record sha256
      afa8e6ccad39853ab26a6fc21f747ec5dc7686d0cd7c09884b933e15b4844b3d
      response sha256
      d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
      retrieved at
      2026-09-09T23:46:57.614689+00:00
      publication date
      display
      2013 Oct
      precision
      month
      year
      2013
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23850450/
      title
      Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer.

      Preserved source evidence · Not medical advice